Advertisement

Index by author

October 01, 1999; Volume 56,Issue 4

A

  1. Amin, Jahanshah

    1. Differential Modulation of the γ-Aminobutyric Acid Type C Receptor by Neuroactive Steroids
      Kendall D. W. Morris, Charles N. Moorefield and Jahanshah Amin
      Molecular Pharmacology October 1999, 56 (4) 752-759;

  2. Antal-Szalmás, Péter

    1. Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
      László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
      Molecular Pharmacology October 1999, 56 (4) 824-833;

  3. Ao, Zhaohui

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  4. Ascoli, Mario

    1. A Dileucine-Based Motif in the C-Terminal Tail of the Lutropin/Choriogonadotropin Receptor Inhibits Endocytosis of the Agonist-Receptor Complex
      Kazuto Nakamura and Mario Ascoli
      Molecular Pharmacology October 1999, 56 (4) 728-736;

B

  1. Balzarini, Jan

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  2. Brüne, Bernhard

    1. Protection against Nitric Oxide-Induced Apoptosis in Rat Mesangial Cells Demands Mitogen-Activated Protein Kinases and Reduced Glutathione
      Katrin B. Sandau, Dagmar Callsen and Bernhard Brüne
      Molecular Pharmacology October 1999, 56 (4) 744-751;

  3. Budd, David C.

    1. Cross Talk Between m3-Muscarinic and β2-Adrenergic Receptors at the Level of Receptor Phosphorylation and Desensitization
      David C. Budd, R. A. John Challiss, Kenneth W. Young and Andrew B. Tobin
      Molecular Pharmacology October 1999, 56 (4) 813-823;

C

  1. Cahard, Dominique

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  2. Callsen, Dagmar

    1. Protection against Nitric Oxide-Induced Apoptosis in Rat Mesangial Cells Demands Mitogen-Activated Protein Kinases and Reduced Glutathione
      Katrin B. Sandau, Dagmar Callsen and Bernhard Brüne
      Molecular Pharmacology October 1999, 56 (4) 744-751;

  3. Carr, I. Craig

    1. Regulation of G Protein Activation and Effector Modulation by Fusion Proteins between the Human 5-Hydroxytryptamine1AReceptor and the α Subunit of Gi1α: Differences in Receptor-Constitutive Activity Imparted by Single Amino Acid Substitutions in Gi1α
      Elaine Kellett, I. Craig Carr and Graeme Milligan
      Molecular Pharmacology October 1999, 56 (4) 684-692;

  4. Casper, Robert F.

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

  5. Challiss, R. A. John

    1. Cross Talk Between m3-Muscarinic and β2-Adrenergic Receptors at the Level of Receptor Phosphorylation and Desensitization
      David C. Budd, R. A. John Challiss, Kenneth W. Young and Andrew B. Tobin
      Molecular Pharmacology October 1999, 56 (4) 813-823;

  6. Chiba, P.

    1. The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance
      G. Ecker, M. Huber, D. Schmid and P. Chiba
      Molecular Pharmacology October 1999, 56 (4) 791-796;

  7. Ciolino, Henry P.

    1. Inhibition of Aryl Hydrocarbon-Induced Cytochrome P-450 1A1 Enzyme Activity and CYP1A1 Expression by Resveratrol
      Henry P. Ciolino and Grace Chao Yeh
      Molecular Pharmacology October 1999, 56 (4) 760-767;

D

  1. Davies, Martin

    1. Mutagenesis of the Rat α1 Subunit of the γ-Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
      Susan M. J. Dunn, Martin Davies, Anna Lisa Muntoni and Jeremy J. Lambert
      Molecular Pharmacology October 1999, 56 (4) 768-774;

  2. Davis, Laura

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  3. Davis, T. Gregg

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  4. De Bosscher, Karolien

    1. Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism
      Wim Vanden Berghe, Elisa Francesconi, Karolien De Bosscher, Michèle Resche-Rigon and Guy Haegeman
      Molecular Pharmacology October 1999, 56 (4) 797-806;

  5. De Clercq, Erik

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  6. Douglas, Stephen A.

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  7. Dunn, Susan M. J.

    1. Mutagenesis of the Rat α1 Subunit of the γ-Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
      Susan M. J. Dunn, Martin Davies, Anna Lisa Muntoni and Jeremy J. Lambert
      Molecular Pharmacology October 1999, 56 (4) 768-774;

E

  1. Ecker, G.

    1. The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance
      G. Ecker, M. Huber, D. Schmid and P. Chiba
      Molecular Pharmacology October 1999, 56 (4) 791-796;

  2. Egan, Terrance M.

    1. Properties of the Novel ATP-Gated Ionotropic Receptor Composed of the P2X1 and P2X5 Isoforms
      William R. Haines, Gonzalo E. Torres, Mark M. Voigt and Terrance M. Egan
      Molecular Pharmacology October 1999, 56 (4) 720-727;

  3. Evans, William E.

    1. Human RNase H-Mediated RNA Cleavage from DNA-RNA Duplexes Is Inhibited by 6-Deoxythioguanosine Incorporation into DNA
      Natalia F. Krynetskaia, Eugene Y. Krynetski and William E. Evans
      Molecular Pharmacology October 1999, 56 (4) 841-848;

F

  1. Figler, Heidi

    1. Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells
      Joel Linden, Tami Thai, Heidi Figler, Xiaowei Jin and Anna S. Robeva
      Molecular Pharmacology October 1999, 56 (4) 705-713;

  2. Francesconi, Elisa

    1. Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism
      Wim Vanden Berghe, Elisa Francesconi, Karolien De Bosscher, Michèle Resche-Rigon and Guy Haegeman
      Molecular Pharmacology October 1999, 56 (4) 797-806;

G

  1. Ganglberger, Erika

    1. The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
      Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
      Molecular Pharmacology October 1999, 56 (4) 665-674;

  2. Griswold, Don E.

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

H

  1. Haegeman, Guy

    1. Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism
      Wim Vanden Berghe, Elisa Francesconi, Karolien De Bosscher, Michèle Resche-Rigon and Guy Haegeman
      Molecular Pharmacology October 1999, 56 (4) 797-806;

  2. Haines, William R.

    1. Properties of the Novel ATP-Gated Ionotropic Receptor Composed of the P2X1 and P2X5 Isoforms
      William R. Haines, Gonzalo E. Torres, Mark M. Voigt and Terrance M. Egan
      Molecular Pharmacology October 1999, 56 (4) 720-727;

  3. Hay, Douglas W. P.

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  4. Huang, Xi-Ping

    1. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors
      Xi-Ping Huang, Frederick E. Williams, Steven M. Peseckis and William S. Messer
      Molecular Pharmacology October 1999, 56 (4) 775-783;

  5. Huber, M.

    1. The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance
      G. Ecker, M. Huber, D. Schmid and P. Chiba
      Molecular Pharmacology October 1999, 56 (4) 791-796;

  6. Hurst, Dow P.

    1. The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
      Z. H. Song, Carole-Anne Slowey, Dow P. Hurst and Patricia H. Reggio
      Molecular Pharmacology October 1999, 56 (4) 834-840;

J

  1. Jiang, Dong

    1. Regulation of D1 Dopamine Receptors with Mutations of Protein Kinase Phosphorylation Sites: Attenuation of the Rate of Agonist-Induced Desensitization
      Dong Jiang and David R. Sibley
      Molecular Pharmacology October 1999, 56 (4) 675-683;

  2. Jin, Xiaowei

    1. Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells
      Joel Linden, Tami Thai, Heidi Figler, Xiaowei Jin and Anna S. Robeva
      Molecular Pharmacology October 1999, 56 (4) 705-713;

  3. Jolivet, André

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

K

  1. Karlic, Heidi I.

    1. The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
      Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
      Molecular Pharmacology October 1999, 56 (4) 665-674;

  2. Kellett, Elaine

    1. Regulation of G Protein Activation and Effector Modulation by Fusion Proteins between the Human 5-Hydroxytryptamine1AReceptor and the α Subunit of Gi1α: Differences in Receptor-Constitutive Activity Imparted by Single Amino Acid Substitutions in Gi1α
      Elaine Kellett, I. Craig Carr and Graeme Milligan
      Molecular Pharmacology October 1999, 56 (4) 684-692;

  3. Kiedrowski, Lech

    1. Elevated Extracellular K+ Concentrations InhibitN-Methyl-d-Aspartate-Induced Ca2+ Influx and Excitotoxicity
      Lech Kiedrowski
      Molecular Pharmacology October 1999, 56 (4) 737-743;

  4. Koenderink, Jan B.

    1. Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells
      Rémon A. M. H. Van Aubel, Jan B. Koenderink, Janny G. P. Peters, Carel H. Van Os and Frans G. M. Russel
      Molecular Pharmacology October 1999, 56 (4) 714-719;

  5. Krynetskaia, Natalia F.

    1. Human RNase H-Mediated RNA Cleavage from DNA-RNA Duplexes Is Inhibited by 6-Deoxythioguanosine Incorporation into DNA
      Natalia F. Krynetskaia, Eugene Y. Krynetski and William E. Evans
      Molecular Pharmacology October 1999, 56 (4) 841-848;

  6. Krynetski, Eugene Y.

    1. Human RNase H-Mediated RNA Cleavage from DNA-RNA Duplexes Is Inhibited by 6-Deoxythioguanosine Incorporation into DNA
      Natalia F. Krynetskaia, Eugene Y. Krynetski and William E. Evans
      Molecular Pharmacology October 1999, 56 (4) 841-848;

L

  1. Lambert, Jeremy J.

    1. Mutagenesis of the Rat α1 Subunit of the γ-Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
      Susan M. J. Dunn, Martin Davies, Anna Lisa Muntoni and Jeremy J. Lambert
      Molecular Pharmacology October 1999, 56 (4) 768-774;

  2. Linden, Joel

    1. Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells
      Joel Linden, Tami Thai, Heidi Figler, Xiaowei Jin and Anna S. Robeva
      Molecular Pharmacology October 1999, 56 (4) 705-713;

  3. Luttmann, Mark A.

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

M

  1. Marian, Brigitte

    1. The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
      Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
      Molecular Pharmacology October 1999, 56 (4) 665-674;

  2. Martin, Lenox D.

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  3. McGuigan, Christopher

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  4. Messer, William S.

    1. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors
      Xi-Ping Huang, Frederick E. Williams, Steven M. Peseckis and William S. Messer
      Molecular Pharmacology October 1999, 56 (4) 775-783;

  5. Milgrom, Edwin

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

  6. Milligan, Graeme

    1. Regulation of G Protein Activation and Effector Modulation by Fusion Proteins between the Human 5-Hydroxytryptamine1AReceptor and the α Subunit of Gi1α: Differences in Receptor-Constitutive Activity Imparted by Single Amino Acid Substitutions in Gi1α
      Elaine Kellett, I. Craig Carr and Graeme Milligan
      Molecular Pharmacology October 1999, 56 (4) 684-692;

  7. Moorefield, Charles N.

    1. Differential Modulation of the γ-Aminobutyric Acid Type C Receptor by Neuroactive Steroids
      Kendall D. W. Morris, Charles N. Moorefield and Jahanshah Amin
      Molecular Pharmacology October 1999, 56 (4) 752-759;

  8. Morris, Kendall D. W.

    1. Differential Modulation of the γ-Aminobutyric Acid Type C Receptor by Neuroactive Steroids
      Kendall D. W. Morris, Charles N. Moorefield and Jahanshah Amin
      Molecular Pharmacology October 1999, 56 (4) 752-759;

  9. Muntoni, Anna Lisa

    1. Mutagenesis of the Rat α1 Subunit of the γ-Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
      Susan M. J. Dunn, Martin Davies, Anna Lisa Muntoni and Jeremy J. Lambert
      Molecular Pharmacology October 1999, 56 (4) 768-774;

N

  1. Naesens, Lieve

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  2. Nakamura, Kazuto

    1. A Dileucine-Based Motif in the C-Terminal Tail of the Lutropin/Choriogonadotropin Receptor Inhibits Endocytosis of the Agonist-Receptor Complex
      Kazuto Nakamura and Mario Ascoli
      Molecular Pharmacology October 1999, 56 (4) 728-736;

  3. Nambi, Ponnal

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

O

  1. O’Connor, Michael

    1. Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
      László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
      Molecular Pharmacology October 1999, 56 (4) 824-833;

  2. Ohlstein, Eliot H.

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

  3. Ohshima, Hiroshi

    1. Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
      László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
      Molecular Pharmacology October 1999, 56 (4) 824-833;

P

  1. Pathirana, Ranjith

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  2. Paukovits, Johanna B.

    1. The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
      Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
      Molecular Pharmacology October 1999, 56 (4) 665-674;

  3. Paukovits, Walter R.

    1. The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
      Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
      Molecular Pharmacology October 1999, 56 (4) 665-674;

  4. Peseckis, Steven M.

    1. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors
      Xi-Ping Huang, Frederick E. Williams, Steven M. Peseckis and William S. Messer
      Molecular Pharmacology October 1999, 56 (4) 775-783;

  5. Peters, Janny G. P.

    1. Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells
      Rémon A. M. H. Van Aubel, Jan B. Koenderink, Janny G. P. Peters, Carel H. Van Os and Frans G. M. Russel
      Molecular Pharmacology October 1999, 56 (4) 714-719;

  6. Pullen, Mark

    1. Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation
      Don E. Griswold, Stephen A. Douglas, Lenox D. Martin, T. Gregg Davis, Laura Davis, Zhaohui Ao, Mark A. Luttmann, Mark Pullen, Ponnal Nambi, Douglas W. P. Hay and Eliot H. Ohlstein
      Molecular Pharmacology October 1999, 56 (4) 807-812;

Q

  1. Quesne, Monique

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

R

  1. Reggio, Patricia H.

    1. The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
      Z. H. Song, Carole-Anne Slowey, Dow P. Hurst and Patricia H. Reggio
      Molecular Pharmacology October 1999, 56 (4) 834-840;

  2. Resche-Rigon, Michèle

    1. Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism
      Wim Vanden Berghe, Elisa Francesconi, Karolien De Bosscher, Michèle Resche-Rigon and Guy Haegeman
      Molecular Pharmacology October 1999, 56 (4) 797-806;

  3. Robeva, Anna S.

    1. Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells
      Joel Linden, Tami Thai, Heidi Figler, Xiaowei Jin and Anna S. Robeva
      Molecular Pharmacology October 1999, 56 (4) 705-713;

  4. Rogers, Ian M.

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

  5. Russel, Frans G. M.

    1. Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells
      Rémon A. M. H. Van Aubel, Jan B. Koenderink, Janny G. P. Peters, Carel H. Van Os and Frans G. M. Russel
      Molecular Pharmacology October 1999, 56 (4) 714-719;

  6. Rutter, Rosalia

    1. The Hemoregulatory Peptide pEEDCK May Inhibit Stem Cell Proliferation via Hydropathic Binding to Antisense Sequence Motifs in Interleukin-11 and Other Growth Factors
      Johanna B. Paukovits, Rosalia Rutter, Erika Ganglberger, Heidi I. Karlic, Brigitte Marian and Walter R. Paukovits
      Molecular Pharmacology October 1999, 56 (4) 665-674;

S

  1. Saboulard, Didier

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  2. Salgado, Antonio

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  3. Sandau, Katrin B.

    1. Protection against Nitric Oxide-Induced Apoptosis in Rat Mesangial Cells Demands Mitogen-Activated Protein Kinases and Reduced Glutathione
      Katrin B. Sandau, Dagmar Callsen and Bernhard Brüne
      Molecular Pharmacology October 1999, 56 (4) 744-751;

  4. Savouret, Jean-François

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

  5. Schmid, D.

    1. The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance
      G. Ecker, M. Huber, D. Schmid and P. Chiba
      Molecular Pharmacology October 1999, 56 (4) 791-796;

  6. Scott, Gwen S.

    1. Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
      László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
      Molecular Pharmacology October 1999, 56 (4) 824-833;

  7. Shirota, Takuhiko

    1. Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity
      Robert F. Casper, Monique Quesne, Ian M. Rogers, Takuhiko Shirota, André Jolivet, Edwin Milgrom and Jean-François Savouret
      Molecular Pharmacology October 1999, 56 (4) 784-790;

  8. Sibley, David R.

    1. Regulation of D1 Dopamine Receptors with Mutations of Protein Kinase Phosphorylation Sites: Attenuation of the Rate of Agonist-Induced Desensitization
      Dong Jiang and David R. Sibley
      Molecular Pharmacology October 1999, 56 (4) 675-683;

  9. Slowey, Carole-Anne

    1. The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
      Z. H. Song, Carole-Anne Slowey, Dow P. Hurst and Patricia H. Reggio
      Molecular Pharmacology October 1999, 56 (4) 834-840;

  10. Song, Z. H.

    1. The Difference between the CB1 and CB2Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
      Z. H. Song, Carole-Anne Slowey, Dow P. Hurst and Patricia H. Reggio
      Molecular Pharmacology October 1999, 56 (4) 834-840;

  11. Szabó, Csaba

    1. Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
      László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
      Molecular Pharmacology October 1999, 56 (4) 824-833;

T

  1. Thai, Tami

    1. Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells
      Joel Linden, Tami Thai, Heidi Figler, Xiaowei Jin and Anna S. Robeva
      Molecular Pharmacology October 1999, 56 (4) 705-713;

  2. Tobin, Andrew B.

    1. Cross Talk Between m3-Muscarinic and β2-Adrenergic Receptors at the Level of Receptor Phosphorylation and Desensitization
      David C. Budd, R. A. John Challiss, Kenneth W. Young and Andrew B. Tobin
      Molecular Pharmacology October 1999, 56 (4) 813-823;

  3. Torres, Gonzalo E.

    1. Properties of the Novel ATP-Gated Ionotropic Receptor Composed of the P2X1 and P2X5 Isoforms
      William R. Haines, Gonzalo E. Torres, Mark M. Voigt and Terrance M. Egan
      Molecular Pharmacology October 1999, 56 (4) 720-727;

V

  1. Van Aubel, Rémon A. M. H.

    1. Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells
      Rémon A. M. H. Van Aubel, Jan B. Koenderink, Janny G. P. Peters, Carel H. Van Os and Frans G. M. Russel
      Molecular Pharmacology October 1999, 56 (4) 714-719;

  2. Vanden Berghe, Wim

    1. Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism
      Wim Vanden Berghe, Elisa Francesconi, Karolien De Bosscher, Michèle Resche-Rigon and Guy Haegeman
      Molecular Pharmacology October 1999, 56 (4) 797-806;

  3. Van Os, Carel H.

    1. Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells
      Rémon A. M. H. Van Aubel, Jan B. Koenderink, Janny G. P. Peters, Carel H. Van Os and Frans G. M. Russel
      Molecular Pharmacology October 1999, 56 (4) 714-719;

  4. Velazquez, Sonsoles

    1. Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine
      Didier Saboulard, Lieve Naesens, Dominique Cahard, Antonio Salgado, Ranjith Pathirana, Sonsoles Velazquez, Christopher McGuigan, Erik De Clercq and Jan Balzarini
      Molecular Pharmacology October 1999, 56 (4) 693-704;

  5. Virág, László

    1. Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity
      László Virág, Gwen S. Scott, Péter Antal-Szalmás, Michael O’Connor, Hiroshi Ohshima and Csaba Szabó
      Molecular Pharmacology October 1999, 56 (4) 824-833;

  6. Voigt, Mark M.

    1. Properties of the Novel ATP-Gated Ionotropic Receptor Composed of the P2X1 and P2X5 Isoforms
      William R. Haines, Gonzalo E. Torres, Mark M. Voigt and Terrance M. Egan
      Molecular Pharmacology October 1999, 56 (4) 720-727;

W

  1. Williams, Frederick E.

    1. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors
      Xi-Ping Huang, Frederick E. Williams, Steven M. Peseckis and William S. Messer
      Molecular Pharmacology October 1999, 56 (4) 775-783;

Y

  1. Yeh, Grace Chao

    1. Inhibition of Aryl Hydrocarbon-Induced Cytochrome P-450 1A1 Enzyme Activity and CYP1A1 Expression by Resveratrol
      Henry P. Ciolino and Grace Chao Yeh
      Molecular Pharmacology October 1999, 56 (4) 760-767;

  2. Young, Kenneth W.

    1. Cross Talk Between m3-Muscarinic and β2-Adrenergic Receptors at the Level of Receptor Phosphorylation and Desensitization
      David C. Budd, R. A. John Challiss, Kenneth W. Young and Andrew B. Tobin
      Molecular Pharmacology October 1999, 56 (4) 813-823;
Back to top

In this issue

Advertisement